Meet the Pfizer Executive Leadership Team: Olivier Brandicourt Olivier Brandicourt, M.D., is President and General Manager of the Emerging Markets and Established Products Business Units. He has 25 years of international experience in the pharmaceutical industry including executive responsibilities in France, the United States, Canada and the United Kingdom. He has held senior operational positions […]
Merck and Israel’s Maccabi Healthcare to Leverage Unique Real-World Database to Inform Novel Health Approaches Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Maccabi Healthcare Services, a two million-member health care provider in Israel, are starting a new, multi-year agreement to leverage real-world data from Maccabi’s unique longitudinal database to […]
Pfizer Pipeline: New Drugs In The Making (August 9, 2013) – Pfizer is in the process of developing the following new drugs that may prove very useful in the field of Psychiatry drugs: AAC-001 (Phase 2): New Alzheimer’s disease vaccine AAB-003 (Phase 1): New biologic Alzheimer’s treatment SAM-760 (Phase 3): New Alzheimer’s treatment PF-04958242 (Phase […]
Pfizer Accolades 2013 June QUESTAR Award – The International Awards Festival for Excellence in Video Communications Pfizer was awarded the Grand — best of category — in Annual Reports in the 2013 Questar Awards. Telly Award – For over a quarter century, the Telly statuette has been a symbol of creative excellence. Pfizer was awarded […]